Essex Woodlands Management’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Essex Woodlands Management’s Portfolio ENTL Stock Details ENTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-3,231,656	Closed	-$77.6M	–	10
2017 Q4	$77.6M	Hold	3,231,656	–	–	14.02%	5
2017 Q3	$59.7M	Hold	3,231,656	–	–	10.58%	5
2017 Q2	$53.5M	Hold	3,231,656	–	–	9.68%	5
2017 Q1	$44.6M	Sell	3,231,656 -581,541	-15%	-$9.34M	10.18%	4
2016 Q4	$72.3M	Hold	3,813,197	–	–	16.5%	3
2016 Q3	$84.6M	Hold	3,813,197	–	–	17.6%	2
2016 Q2	$69.7M	Hold	3,813,197	–	–	17.55%	2
2016 Q1	$69.4M	Hold	3,813,197	–	–	18.15%	3
2015 Q4	$64.3M	Hold	3,813,197	–	–	11.76%	4
2015 Q3	$68.7M	Hold	3,813,197	–	–	12.56%	4
2015 Q2	$98.6M	Buy	3,813,197 +1	+0%	+$25	17.8%	4
2015 Q1	$83.5M	Buy	+3,813,196	New	+$82.3M	16.57%	3

Essex Woodlands Management's ENTL Position: Q1 2018 in Review

Essex Woodlands Management sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 3,231,656 shares — an estimated $77.6M sold.

Essex Woodlands Management first reported a position in ENTL in Q1 2015 and held it in 12 quarters. The position peaked at $98.6M in Q2 2015. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

Essex Woodlands Management reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Essex Woodlands Management sold 3,231,656 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $77.6M.
Essex Woodlands Management first reported a position in Entellus Medical, Inc. Common Stock in Q1 2015 and held it in 12 quarters.
Essex Woodlands Management's Entellus Medical, Inc. Common Stock position peaked at $98.6M in Q2 2015.
0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.

Based on Essex Woodlands Management's 13F filing for Q1 2018, filed 15 May 2018.